Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.

 

Additional Coronavirus Updates >

MENU

Fox Chase Cancer Center News

December 8, 2020

Studies Identifying Structure, Role of Integrin-Activating Proteins Could Lead to New Therapeutic Targets for Cancer

PHILADELPHIA (December 8, 2020) – Researchers from Fox Chase Cancer Center have recently publish a series of collaborative studies that could help facilitate the development of new therapeutic agents for cancer treatment by altering integrin activity.

December 7, 2020

Fox Chase’s Namrata Vijayvergia Receives 40 Under 40 in Cancer Award

PHILADELPHIA (December 7, 2020)—Namrata (Neena) Vijayvergia, MD, assistant chief of gastrointestinal medical oncology at Fox Chase Cancer Center, was recently named a 2020 recipient of the 40 Under 40 in Cancer Award.

December 7, 2020

Prognostic, Predictive Markers Have Growing Importance in CLL Management

PHILADELPHIA (December 7, 2020) – Y. Lynn Wang, MD, PhD, FACP, a professor in the Department of Pathology and Blood Cell Development and Function program at Fox Chase Cancer Center, recently published a comprehensive review of molecular biomarkers in chronic lymphocytic leukemia (CLL), the most common leukemia in adults in the United States.

December 3, 2020

Fox Chase Researchers Find Association Between Rapid Recurrence and Poor Survival Outcomes in Head and Neck Cancer

PHILADELPHIA (December 3, 2020)—Researchers at Fox Chase Cancer Center recently published new data showing that patients with head and neck cancer (HNC) recur just weeks after a complete operation at an under-appreciated rate and that this is associated with poor survival outcomes.

December 2, 2020

Fox Chase Researchers Find Care of Head and Neck Cancer Differs Between Patients With Localized Versus Advanced Disease

PHILADELPHIA (December 2, 2020)—In a recently published study, researchers at Fox Chase Cancer Center found that more elderly patients with localized head and neck cancer received multidisciplinary care compared with patients with advanced-stage disease.

November 30, 2020

Fox Chase Researchers Warn That Website Terms of Use May Deter Research

PHILADELPHIA (November 30, 2020)–Researchers at Fox Chase Cancer Center have published a letter cautioning that website terms of use may limit how researchers can use online data, particularly with respect to online physician review information. Websites may require researchers to obtain permission to use online resources in research.

November 25, 2020

Fox Chase Researchers Use New CRISPR Library Screening Method to Identify Drug Response, Resistance Mechanisms in Hodgkin Lymphoma Models

PHILADELPHIA (November 25, 2020)—In a recent study, researchers at Fox Chase Cancer Center used a new screening method to identify a previously unrecognized mechanism for resistance and responsiveness in Hodgkin lymphoma models being treated with brentuximab vedotin, also known by its brand name, Adcetris.

November 25, 2020

Five Fox Chase Cancer Center Physicians Named Top Docs 2020 by Main Line Today

PHILADELPHIA (November 25, 2020)— Five Fox Chase Cancer Center physicians have been named as 2020 Top Docs by Main Line Today. Top Docs were selected by regional physicians from a variety of practices, and the physicians from Fox Chase who were honored cover a range of oncologic specialties.

Pages

Connect with Fox Chase